Navigation Links
Regenesis Biomedical Advances Corporate Strategy by Appointing Vice President of Marketing
Date:5/1/2008

g them to replicate and to produce natural growth factors and other gene expression products, which facilitate reduction of the pain and edema associated with post-operative wound healing in soft tissues. We believe Provant is effective, economical, and easy-to-use.

About Regenesis Biomedical

Regenesis Biomedical, Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products. Regenesis developed, patented, and now markets the Provant Wound Therapy System. Our customers include health care facilities and providers that serve patients with wounds being treated by acute care hospitals, long- term acute care hospitals, skilled nursing facilities, rehabilitation centers, home health care agencies, and wound care clinics.

Contact:

Regenesis Biomedical, Inc.

Media: Scott Robey, VP Marketing robey@regenesisbiomedical.com

Clinicians: Rick Isenberg, MD, VP Clinical Affairs

isenberg@regenesisbiomedical.com

Investors: Virginia Rybski, Acting President

rybski@regenesisbiomedical.com

http://www.regenesisbiomedical.com

480-970-4970


'/>"/>
SOURCE Regenesis Biomedical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
2. Boston Biomedical Research Institute Maintains Baa3 Rating from Moodys
3. SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.
4. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target
5. LifeNet Health(R) Unveils New Biomedical Spine Implant
6. MIT researcher addresses biomedical engineering challenges
7. mNEMOSCIENCE GmbH Announces Global Licensing Agreement With Aporo Biomedical
8. Bookham to Enter Biomedical Illumination Market
9. ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
10. New NIST mini-sensor may have biomedical and security applications
11. BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 Dyadic International, Inc. (Pink Sheets: ... its collaboration with The Scripps Research Institute ("Scripps") ... re-annotate the genome of Dyadic,s patented and proprietary ... continuation of the successful relationship between the two ... engaged Scripps to annotate the C1 genome for ...
(Date:12/14/2009)... -- Nektar Therapeutics (Nasdaq: NKTR ) announced ... serve on its board of directors. Winger ... 35 years of experience in corporate management, financial ... extensive industry perspective at an important time in ... and CEO of Nektar and member of the ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today ... offering have exercised in full their option to ... at the public offering price of $24.75 per ... the size of the offering to an aggregate ... expects to receive net proceeds from the offering ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer therapeutics company, ... the,US, the Tulane Cancer Center, New Orleans, ... clinical study of Alpharadin in men with,castration-resistant ... has metastasized to the skeleton. , ... SYMptomatic Prostate CAncer) study is a,double-blind, randomized, ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4
... HONG KONG, Feb. 18 /PRNewswire-Asia/ -- Obio ... business growth ticket to the,international pharmaceutical arena. ... backed up by strong international investors including ... Group, Tai Sang Land Properties,Limited, Yu Hwa ...
... PharmaNet Development Group, Inc. (the "Company") (Nasdaq: ... to innovative pharmaceutical, biotechnology, generic drug and medical device ... in Sao Paulo, Brazil to further enhance its Latin ... Latin America since 2002 with a network of field-based ...
... Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE ... months ended December 31, 2008. Net loss for the three ... per share, compared with a net loss of $1,049,838 or ... 31, 2007. This increase in net loss was primarily ...
Other Biology Technology:Obio Pharmaceutical Announces Product Growth Strategy 2Obio Pharmaceutical Announces Product Growth Strategy 3PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 2PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 3PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 4PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 5Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 2Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 3Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 4Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 5Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 6Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 7
(Date:12/11/2009)... wild apples that could be an ancestor of today,s ... Asia. A new study comparing the diversity of recently ... Armenia with previously collected varieties originating in Russia and ... collection that will make M. orientalis more ... identify and record the genetic diversity of these wild ...
(Date:12/11/2009)... stress collectively weigh and initiate different survival strategies say ... strategic decisions that affect their health, wealth and the ... this week in the early online edition of the ... , was accomplished when the scientists applied the mathematical ... of genes and proteins that colonies of bacteria rely ...
(Date:12/11/2009)... University has granted an 18-month, exclusive option to ... insulin analogs. The company must reach certain milestones ... an exclusive license on therapies designed to help ... developing treatments that it hopes will become an ... insulin market. Insulin is a therapeutic protein used ...
Breaking Biology News(10 mins):Understanding apples' ancestors 2Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5Case Western Reserve University grants option to startup Thermalin Diabetes Inc. 2Dee Snider Leads 2009 March of Dimes Bikers for Babies 28R 29 48644 1Dee Snider Leads 2009 March of Dimes Bikers for Babies 28R 29 48644 2Oncology Program at Texas Health Dallas Receives Outstanding Achievement Award 48641 1Oncology Program at Texas Health Dallas Receives Outstanding Achievement Award 48641 2Protein Branded As Culprit in Mad Cow Disease 48638 1Protein Branded As Culprit in Mad Cow Disease 48638 2
... of Medicine scientists in the Department of Physiology and Cell Biology ... chromosome that may have significant implications for male infertility and contraception. ... This important discovery has been published in Nature ... biomedical research based upon the impact factor. , ...
... levels of carbon dioxide in the atmosphere are a ... The lack of atmospheric carbon dioxide (CO 2 ) ... their aquatic relatives, microalgae. , For plants and microalgae, ... their photosynthesis process that, along with sunlight, manufactures sugars ...
... Max Perutz was a campaigner for humanitarian causes, essayist, and ... has just been released by Cold Spring Harbor Laboratory Press. ... letters in the book What a Time I am ... life through his own vivid, erudite, and humorous pen. , ...
Other Biology News:Small RNAs can play critical roles in male infertility/contraception 2ISU researcher identifies protein that concentrates carbon dioxide in algae 2Selected personal letters of Max Perutz are released in new book 2
... Scientific has a long and outstanding ... apparatus. Several years ago we became ... microdispenser was being modified to inject ... by redesigning the microdispenser to eliminate ...
The Programmable MP-3500P-F Power Supply can be applied for any Microfluidic application....
... Science Smart Minis 150V power supply (Cat. ... power supplies designed to meet most electrophoresis ... use unit. The Minis 150V power supply ... Minis Power Supply is designed for individuals ...
Rabbit polyclonal to Synapsin II ( Abpromise for all tested applications). entrezGeneID: 6854 SwissProtID: Q92777...
Biology Products: